Novartis announces MET inhibitor Tabrecta approved in Japan for advanced non-small cell lung cancer with METex14 Read more
Developing custom syringes for highly viscous formulations to be discussed at the Pre-filled Syringes San Francisco Conference Read more
Allergan and Molecular Partners Receive Complete Response Letter from FDA on BLA for Abicipar pegol Read more
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Read more
PPD Expands Laboratory Test Portfolio for COVID-19 Therapy and Vaccine Development Programs Read more
EMD Serono Initiates First Clinical Trial of TLR7 and 8 Inhibitor as a Potential Treatment for Severe Symptoms of Covid-19 Infection Read more
Theravance Biopharma doses first patient in phase 2 Covid-19 trial with JAKi inhibitor TD-0903 Read more